|
1
|
Goodenberger ML and Jenkins RB: Genetics
of adult glioma. Cancer Genet. 205:613–621. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Buck JR, McKinley ET, Fu A, Abel TW,
Thompson RC, Chambless L, Watchmaker JM, Harty JP, Cooper MK and
Manning HC: Preclinical TSPO Ligand PET to Visualize Human Glioma
Xenotransplants: A Preliminary Study. PLoS One. 10:e01416592015.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Codo P, Weller M, Meister G, Szabo E,
Steinle A, Wolter M, Reifenberger G and Roth P: MicroRNA-mediated
down-regulation of NKG2D ligands contributes to glioma immune
escape. Oncotarget. 5:7651–7662. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Breunig JJ, Levy R, Antonuk CD, Molina J,
Dutra-Clarke M, Park H, Akhtar AA, Kim GB, Hu X, Bannykh SI, et al:
Ets factors regulate neural stem cell depletion and gliogenesis in
Ras Pathway Glioma. Cell Reports. 12:258–271. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Boisselier B, Gállego Pérez-Larraya J,
Rossetto M, Labussière M, Ciccarino P, Marie Y, Delattre JY and
Sanson M: Detection of IDH1 mutation in the plasma of patients with
glioma. Neurology. 79:1693–1698. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Blough MD, Beauchamp DC, Westgate MR,
Kelly JJ and Cairncross JG: Effect of aberrant p53 function on
temozolomide sensitivity of glioma cell lines and brain tumor
initiating cells from glioblastoma. J Neurooncol. 102:1–7. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lalezari S, Chou AP, Tran A, Solis OE,
Khanlou N, Chen W, Li S, Carrillo JA, Chowdhury R, Selfridge J, et
al: Combined analysis of O6-methylguanine-DNA methyltransferase
protein expression and promoter methylation provides optimized
prognostication of glioblastoma outcome. Neuro-oncol. 15:370–381.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Parkinson JF, Wheeler HR, Clarkson A,
McKenzie CA, Biggs MT, Little NS, Cook RJ, Messina M, Robinson BG
and McDonald KL: Variation of O(6)-methylguanine-DNA
methyltransferase (MGMT) promoter methylation in serial samples in
glioblastoma. J Neurooncol. 87:71–78. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Aboody KS, Brown A, Rainov NG, Bower KA,
Liu S, Yang W, Small JE, Herrlinger U, Ourednik V, Black PM, et al:
Neural stem cells display extensive tropism for pathology in adult
brain: Evidence from intracranial gliomas. Proc Natl Acad Sci USA.
97:12846–12851. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Barami K: Relationship of neural stem
cells with their vascular niche: implications in the malignant
progression of gliomas. J Clin Neurosci. 15:1193–1197. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sanai N, Alvarez-Buylla A and Berger MS:
Neural stem cells and the origin of gliomas. N Engl J Med.
353:811–822. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Grauer OM, Molling JW, Bennink E, Toonen
LW, Sutmuller RP, Nierkens S and Adema GJ: TLR ligands in the local
treatment of established intracerebral murine gliomas. J Immunol.
181:6720–6729. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Szatmári T, Lumniczky K, Désaknai S,
Trajcevski S, Hídvégi EJ, Hamada H and Sáfrány G: Detailed
characterization of the mouse glioma 261 tumor model for
experimental glioblastoma therapy. Cancer Sci. 97:546–553. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ostrom QT, Bauchet L, Davis FG, Deltour I,
Fisher JL, Langer CE, Pekmezci M, Schwartzbaum JA, Turner MC, Walsh
KM, Wrensch MR and Barnholtz-Sloan JS: The epidemiology of glioma
in adults: a ‘state of the science’ review. Neuro-Oncol.
16:899–913. 2014. View Article : Google Scholar
|
|
15
|
Lee SG, Kim K, Kegelman TP, Dash R, Das
SK, Choi JK, Emdad L, Howlett EL, Jeon HY, Su ZZ, et al: Oncogene
AEG-1 promotes glioma-induced neurodegeneration by increasing
glutamate excitotoxicity. Cancer Res. 71:6514–6523. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sano M, Genkai N, Yajima N, Tsuchiya N,
Homma J, Tanaka R, Miki T and Yamanaka R: Expression level of ECT2
proto-oncogene correlates with prognosis in glioma patients. Oncol
Rep. 16:1093–1098. 2006.PubMed/NCBI
|
|
17
|
ten Haaf A, Bektas N, von Serenyi S, Losen
I, Arweiler EC, Hartmann A, Knüchel R and Dahl E: Expression of the
glioma-associated oncogene homolog (GLI) 1 in human breast cancer
is associated with unfavourable overall survival. BMC Cancer.
9:2982009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Suzuki T, Izumoto S, Wada K, Fujimoto Y,
Maruno M, Yamasaki M, Kanemura Y, Shimazaki T, Okano H and
Yoshimine T: Inhibition of glioma cell proliferation by neural stem
cell factor. J Neurooncol. 74:233–239. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tran TT, Uhl M, Ma JY, Janssen L, Sriram
V, Aulwurm S, Kerr I, Lam A, Webb HK, Kapoun AM, et al: Inhibiting
TGF-beta signaling restores immune surveillance in the SMA-560
glioma model. Neuro-oncol. 9:259–270. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Orian JM, Vasilopoulos K, Yoshida S, Kaye
AH, Chow CW and Gonzales MF: Overexpression of multiple oncogenes
related to histological grade of astrocytic glioma. Br J Cancer.
66:106–112. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhu R, Kang S and Wu D: Expression of p53,
c-erbB1, c-myc and p16 gene proteins in human glioma. Zhonghua Bing
Li Xue Za Zhi. 26:343–345. 1997.(In Chinese). PubMed/NCBI
|
|
22
|
Zheng X, Yao Y, Xu Q, Tu K and Liu Q:
Evaluation of glioma-associated oncogene 1 expression and its
correlation with the expression of sonic hedgehog, E-cadherin and
S100a4 in human hepatocellular carcinoma. Mol Med Rep. 3:965–970.
2010.PubMed/NCBI
|
|
23
|
Ohta M, Tateishi K, Kanai F, Watabe H,
Kondo S, Guleng B, Tanaka Y, Asaoka Y, Jazag A, Imamura J, et al:
p53-Independent negative regulation of p21/cyclin-dependent
kinase-interacting protein 1 by the sonic
hedgehog-glioma-associated oncogene 1 pathway in gastric carcinoma
cells. Cancer Res. 65:10822–10829. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Godlewski J, Nowicki MO, Bronisz A,
Williams S, Otsuki A, Nuovo G, Raychaudhury A, Newton HB, Chiocca
EA and Lawler S: Targeting of the Bmi-1 oncogene/stem cell renewal
factor by microRNA-128 inhibits glioma proliferation and
self-renewal. Cancer Res. 68:9125–9130. 2008. View Article : Google Scholar : PubMed/NCBI
|
